Drucker Wealth 3.0 LLC lessened its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 3.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,071 shares of the company’s stock after selling 118 shares during the period. Drucker Wealth 3.0 LLC’s holdings in Procter & Gamble were worth $532,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the stock. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble during the second quarter valued at about $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble in the 3rd quarter worth approximately $33,000. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble during the second quarter valued at about $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 2.54 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 83,080 shares of company stock worth $14,629,038. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter last year, the business posted $1.83 EPS. Analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. Procter & Gamble’s payout ratio is currently 69.48%.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on PG shares. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Wells Fargo & Company upped their price objective on Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 22nd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- The 3 Best Retail Stocks to Shop for in August
- Is Papa John’s Ready to Rise Again?
- There Are Different Types of Stock To Invest In
- Should You Buy the Dip in Real Estate Stocks Now?
- Best Stocks Under $5.00
- Here’s Why Best Buy Stock Could Be a Gift for Investors in 2025
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.